These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
340 related items for PubMed ID: 15622489
1. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH. Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, Shiratori K. J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489 [Abstract] [Full Text] [Related]
2. Hepatocellular carcinoma with nonalcoholic steatohepatitis. Mori S, Yamasaki T, Sakaida I, Takami T, Sakaguchi E, Kimura T, Kurokawa F, Maeyama S, Okita K. J Gastroenterol; 2004 Dec; 39(4):391-6. PubMed ID: 15168253 [Abstract] [Full Text] [Related]
3. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH. Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [Abstract] [Full Text] [Related]
4. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC. Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [Abstract] [Full Text] [Related]
6. Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder. Ikeda H, Suzuki M, Takahashi H, Kobayashi M, Okuse N, Moriya H, Koike J, Maeyama S, Yotsuyanagi H, Itoh F. Pathol Int; 2006 Jan; 56(1):40-5. PubMed ID: 16398679 [Abstract] [Full Text] [Related]
7. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F. Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485 [Abstract] [Full Text] [Related]
8. Surgically resected hepatocellular carcinomas in patients with non-alcoholic steatohepatitis. Maeda T, Hashimoto K, Kihara Y, Ikegami T, Ishida T, Aimitsu S, Fujiwara M. Hepatogastroenterology; 2008 Mar; 55(85):1404-6. PubMed ID: 18795699 [Abstract] [Full Text] [Related]
9. Primary liver cancers with nonalcoholic steatohepatitis. Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M. Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):827-34. PubMed ID: 17873605 [Abstract] [Full Text] [Related]
10. Natural history of nonalcoholic steatohepatitis. Liou I, Kowdley KV. J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761 [Abstract] [Full Text] [Related]
11. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P. Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619 [Abstract] [Full Text] [Related]
13. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Malik SM, Gupte PA, de Vera ME, Ahmad J. Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869 [Abstract] [Full Text] [Related]
14. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective. Lackner C. Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917 [Abstract] [Full Text] [Related]
15. [A case of ruptured hepatocellular carcinoma originated from nonalcoholic steatohepatitis (NASH)]. Oba A, Kuwabara H, Wakabayashi M, Nakamura H, Sanada T, Tamai S, Baba H, Nakajima K, Goseki N. Gan To Kagaku Ryoho; 2010 Nov; 37(12):2667-9. PubMed ID: 21224674 [Abstract] [Full Text] [Related]
16. [Diagnostic criteria for non-alcoholic steatohepatitis]. Hashimoto E. Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105 [Abstract] [Full Text] [Related]
17. Steatosis and hepatocellular carcinoma risk. Smedile A, Bugianesi E. Eur Rev Med Pharmacol Sci; 2005 Jun; 9(5):291-3. PubMed ID: 16231592 [Abstract] [Full Text] [Related]
18. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Serfaty L, Lemoine M. Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623 [Abstract] [Full Text] [Related]
19. Pathology and biopsy assessment of non-alcoholic fatty liver disease. Straub BK, Schirmacher P. Dig Dis; 2010 Dec; 28(1):197-202. PubMed ID: 20460911 [Abstract] [Full Text] [Related]
20. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228 [Abstract] [Full Text] [Related] Page: [Next] [New Search]